American Healthcare Leader: “Wilkinson Walsh + Eskovitz Help Bayer Stand Its Ground”

wwe Homepage news, News, News

WASHINGTON — After the WW+E team won a decisive trial victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, American Healthcare Leader’s (AHL) Sara Deeter highlighted how Walsh and Eskovitz’s “confidence and strategy” helped Bayer win a “resounding victory” in such a “high stakes” case. Without calling any witnesses in the defense case, the WW+E team — led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin — relied on devastating cross-examinations of plaintiffs’ expert and fact witnesses, which were “pivotal” and “yielded further important insights.” The cross-examinations were so effective that it only took the jury one hour to reject plaintiffs’ claims that Bayer had misrepresented the health benefits of One A Day multivitamins.  The feature acknowledged one of WW+E’s key strategies to engaging with the jury in a case that centered on “relatively complicated biological …

WW+E Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

wwe Homepage news, News, News

WASHINGTON – Wilkinson Walsh + Eskovitz is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of WW+E’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. WW+E won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, WW+E, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, WW+E, led by Kosta Stojilkovic and Rakesh …